Medical Imaging Diagnostics in India: A Deep Patent Base, Thin Startup Activity

What it is

Medical imaging diagnostics uses noninvasive techniques—X-ray, CT, MRI, ultrasound, and nuclear medicine—to visualize internal structures and detect disease. These tests are foundational to modern healthcare, enabling early cancer screening, cardiovascular assessment, neurological evaluation, and infectious disease monitoring.

In India, where the disease burden is high and access to specialists is uneven, imaging plays a critical role in bridging diagnostic gaps. The choice of modality depends on the body part and clinical question, from mammography for breast cancer to chest X-rays for tuberculosis.

The value chain

• Upstream R&D: New imaging modalities, contrast agents, and AI algorithms developed by academic labs and startups.
• Component manufacturing: Specialized parts like X-ray tubes, MRI magnets, and ultrasound transducers—often imported, creating supply chain dependencies.
• Equipment manufacturing: OEMs like Siemens Healthineers, GE HealthCare, and Philips integrate components into full systems; this stage holds significant margin and IP defensibility.
• Distribution & procurement: Logistics and procurement services, critical for reaching tier-2/3 cities in India.
• Service providers: Hospitals, diagnostic chains, and mobile imaging units deliver scans to patients.
• Software & AI analytics: AI-powered computer-aided diagnostics (CAD) tools that interpret images—a high-growth, high-margin layer where Indian startups can compete.
• End users: Radiologists, clinicians, and patients.

Where it's heading

• AI and CAD integration: AI is being embedded into imaging workflows to speed up interpretation and improve accuracy, especially for TB and cancer screening (PFSCM).
• Portable and mobile imaging: Startups like Adialante are redesigning MRI for mobility, expanding access to underserved populations (Y Combinator).
• Supply chain pressures: Tariffs and disruptions are raising costs for capital equipment, pushing hospitals to seek alternative sourcing (TechNation).
• Value-based care: Efforts to eliminate waste in device supply chains are gaining traction, shifting procurement toward outcomes (DAIC).
• Infectious disease imaging: The role of chest X-rays and CT in managing COVID-19 and TB has cemented imaging’s place in public health programs (PFSCM).
• India’s digital health push: The Ayushman Bharat Digital Mission is building a national backbone that could enable large-scale AI testbeds for imaging (PhotonDelta).
• Price sensitivity: Indian healthcare startups must design for affordability, as the market is highly cost-conscious (BioSpectrum India).

The opportunity in India

Our data shows 252 patents mapped to medical imaging diagnostics, with filings rising—a strong signal of inventive activity. Yet our company database captured zero deep-tech firms explicitly referencing the term, suggesting a gap between patenting and commercial startup formation. However, 36 patent-holding entities appear in our patent-linked data, including institutions and individuals.

This indicates that while innovation is happening, it hasn’t yet coalesced into a visible startup cluster. The broader health-life-sciences sector has attracted $2.58 billion across 973 funded companies, but imaging-specific funding remains concentrated in a few AI players like Qure.ai and SigTuple.

The white-space lies in translating India’s patent base into ventures that build affordable, AI-powered diagnostic tools, portable devices, and teleradiology platforms tailored to the country’s vast and varied healthcare needs. With ABDM providing a digital framework, the conditions are ripe for imaging startups that can navigate regulatory pathways and price constraints.

India signal: patents, startups, capital

Our dataset maps 252 patents to medical imaging diagnostics, with momentum rising—published filings are up even before the last two years fully publish, a strong indicator of growing inventive activity. The dominant sector is health-life-sciences, which has seen 973 companies raise a combined $2.58 billion, at a median round size of $1.0 million.

Among patent-holding startups, we count 36 entities, though many are individual inventors or academic institutions. Notable names include Chennai Institute of Technology and MANENTIA ADVISORY, each with two patents. On the funding side, AI-driven imaging startups stand out: Qure.ai has raised $130 million and SigTuple $54.7 million, both at late stages.

The gap between patent output and the thin layer of commercial startups points to an underleveraged opportunity.

In our data

Sources

• Modern Diagnostic Imaging Technique Applications and Risk ... ↗
• Diagnostic Imaging ↗
• How Medical Imaging and Scans Work ↗
• U.S. diagnostic imaging market faces tariff-driven supply chain ... ↗
• Eliminating Waste in the Medical Device Supply Chain | DAIC ↗
• Medical Imaging: Strengthening Healthcare Infrastructure ↗
• Diagnostic Imaging Market Report 2025-2030, By Modality, ... ↗
• Global Medical Imaging Market Size & Outlook, 2026-2033 ↗